Covered recipient · General Payments record
ANNE BERRY TODD
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$2,675.84
- Reported across 162 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $388.92 | 33 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $190.55 | 22 |
| Acerta Pharma LLC | $53.41 | 3 |
| Lilly USA, LLC | $43.60 | 2 |
| Exact Sciences Corporation | $27.53 | 2 |
| GlaxoSmithKline, LLC. | $22.81 | 1 |
| Novo Nordisk AS | $17.95 | 1 |
| ITI, Inc. | $16.88 | 1 |
| Esperion Therapeutics, Inc. | $16.19 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (33)
Sorted by paying entity, then date · as published by CMS
Program year 2024 20182019202020222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $7.56 | 01/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106229395 | CMS |
| ABBVIE INC. | $4.26 | 01/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106229397 | CMS |
| ABBVIE INC. | $5.88 | 01/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106229399 | CMS |
| ABBVIE INC. | $18.54 | 01/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106229401 | CMS |
| ABBVIE INC. | $8.37 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106229403 | CMS |
| ABBVIE INC. | $6.88 | 02/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106229405 | CMS |
| ABBVIE INC. | $12.68 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106229407 | CMS |
| ABBVIE INC. | $6.63 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106229409 | CMS |
| ABBVIE INC. | $6.89 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106229411 | CMS |
| ABBVIE INC. | $7.56 | 04/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106229413 | CMS |
| ABBVIE INC. | $6.86 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106229415 | CMS |
| ABBVIE INC. | $7.64 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106229417 | CMS |
| ABBVIE INC. | $8.94 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106229419 | CMS |
| ABBVIE INC. | $8.01 | 07/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106229421 | CMS |
| ABBVIE INC. | $5.95 | 07/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106229423 | CMS |
| ABBVIE INC. | $6.83 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106229425 | CMS |
| ABBVIE INC. | $7.30 | 08/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106229427 | CMS |
| ABBVIE INC. | $7.38 | 09/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106229429 | CMS |
| ABBVIE INC. | $21.35 | 10/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106229431 | CMS |
| ABBVIE INC. | $6.13 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106229433 | CMS |
| ABBVIE INC. | $11.31 | 11/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106229435 | CMS |
| ABBVIE INC. | $7.60 | 12/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106229437 | CMS |
| AstraZeneca Pharmaceuticals LP | $15.45 | 01/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105541495 | CMS |
| AstraZeneca Pharmaceuticals LP | $17.84 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104234221 | CMS |
| AstraZeneca Pharmaceuticals LP | $20.12 | 08/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105815311 | CMS |
| Esperion Therapeutics, Inc. | $16.19 | 09/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1129457838 | CMS |
| Exact Sciences Corporation | $13.94 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114932583 | CMS |
| Exact Sciences Corporation | $13.59 | 12/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114932587 | CMS |
| GlaxoSmithKline, LLC. | $22.81 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116314689 | CMS |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $16.88 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143333251 | CMS |
| Lilly USA, LLC | $27.59 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136057442 | CMS |
| Lilly USA, LLC | $16.01 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136049703 | CMS |
| Novo Nordisk Inc | $17.95 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097149276 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.